Logo image of BFAC

BATTERY FUTURE ACQUISITION-A (BFAC) Stock Fundamental Analysis

NYSE:BFAC - New York Stock Exchange, Inc. - KYG0888J1085 - Common Stock - Currency: USD

11.14  -0.01 (-0.09%)

Fundamental Rating

2

Taking everything into account, BFAC scores 2 out of 10 in our fundamental rating. BFAC was compared to 0 industry peers in the Unkown industry. While BFAC seems to be doing ok healthwise, there are quite some concerns on its profitability. BFAC is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year BFAC was profitable.
In the past year BFAC has reported a negative cash flow from operations.
BFAC Yearly Net Income VS EBIT VS OCF VS FCFBFAC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 5M 10M 15M 20M

1.2 Ratios

Industry RankSector Rank
ROA 12.33%
ROE 12.56%
ROIC N/A
ROA(3y)5.67%
ROA(5y)N/A
ROE(3y)6.24%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BFAC Yearly ROA, ROE, ROICBFAC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 5 -5 10

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for BFAC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BFAC Yearly Profit, Operating, Gross MarginsBFAC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023

5

2. Health

2.1 Basic Checks

The number of shares outstanding for BFAC has been reduced compared to 1 year ago.
There is no outstanding debt for BFAC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BFAC Yearly Shares OutstandingBFAC Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 10M 20M 30M 40M
BFAC Yearly Total Debt VS Total AssetsBFAC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 100M 200M 300M

2.2 Solvency

An Altman-Z score of 107.45 indicates that BFAC is not in any danger for bankruptcy at the moment.
There is no outstanding debt for BFAC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 107.45
ROIC/WACCN/A
WACCN/A
BFAC Yearly LT Debt VS Equity VS FCFBFAC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 0.08 indicates that BFAC may have some problems paying its short term obligations.
A Quick Ratio of 0.08 indicates that BFAC may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.08
Quick Ratio 0.08
BFAC Yearly Current Assets VS Current LiabilitesBFAC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 1M 2M 3M 4M

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 62.11% over the past year.
EPS 1Y (TTM)62.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.83%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BFAC Yearly Revenue VS EstimatesBFAC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023
BFAC Yearly EPS VS EstimatesBFAC Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023

0

4. Valuation

4.1 Price/Earnings Ratio

BFAC is valuated quite expensively with a Price/Earnings ratio of 30.11.
The average S&P500 Price/Earnings ratio is at 29.63. BFAC is around the same levels.
Industry RankSector Rank
PE 30.11
Fwd PE N/A
BFAC Price Earnings VS Forward Price EarningsBFAC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BFAC Per share dataBFAC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

BFAC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BATTERY FUTURE ACQUISITION-A

NYSE:BFAC (12/13/2024, 8:10:13 PM)

11.14

-0.01 (-0.09%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners78.05%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner Change0%
Market Cap137.13M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 30.11
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 3.33
P/tB 3.33
EV/EBITDA N/A
EPS(TTM)0.37
EY3.32%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0
BVpS3.34
TBVpS3.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 12.33%
ROE 12.56%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)5.67%
ROA(5y)N/A
ROE(3y)6.24%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.08
Quick Ratio 0.08
Altman-Z 107.45
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)62.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.83%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y58.16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y50.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y50.44%
OCF growth 3YN/A
OCF growth 5YN/A